Plasma MMP1 was significantly higher in ESCC patients than that in controls (means ± standard deviations 8.7 ± 7.5 vs. 6.7 ± 4.9 ng/mL; p < 0.0001) (Table 1). Here, MMP1 is linked to esophageal squamous cell carcinoma.